Can Proya export its story to become a global makeup artist?
China’s leading cosmetics maker is seeking a second listing in Hong Kong, aiming to boost its overseas expansion as its top-line revenue growth slows Key Takeaways: Proya is exploring a…
BRIEF: Mao Geping’s profit, revenue up more than 30% in first half of 2025
Cosmetics seller Mao Geping Cosmetics Co. Ltd (1318.HK) said on Tuesday it expects to report revenue between 2.57 billion yuan ($358 million) and 2.6 billion yuan for the first half…
Yatsen CEO declares turnaround with quarterly non-GAAP profit
The cosmetics seller reported a nearly 50% increase in its first-quarter revenue from skincare products as it pivots to the segment from make-up Key Takeaways: Yatsen’s first-quarter net loss narrowed…
Kintor Pharma shifts from cancer drugs to cosmetics as funds run low
The cash-strapped biotech has begun generating its first revenue from over-the-counter cosmetic treatments, as it pivots away from its original oncology drugs Key Takeaways: Kintor Pharma is shifting from its…
Eternal Beauty struts its stuff as Hong Kong’s newest IPO contestant
The perfume company hopes to follow in the footsteps of the well-received IPO last year by cosmetics seller Mao Geping Key Takeaways: Eternal Beauty has filed for a Hong Kong…
BRIEF: Mao Geping surges in Hong Kong trading debut
Shares of cosmetics seller Mao Geping Cosmetics Co. Ltd. (1318.HK) surged in their Hong Kong trading debut on Tuesday, opening nearly 60% above their IPO price of HK$29.80. The stock…
Mao Geping’s Hong Kong IPO gets lift from regulatory nod
The planned listing by China’s second-ranking domestic cosmetics brand has been approved by the Mainland Chinese securities regulator Key Takeaways: Mao Geping’s Hong Kong IPO has been cleared by the…
Recent Articles
RELATED ARTICLES
-
Yatsen CEO declares turnaround with quarterly non-GAAP profit
YSG.US
-
Sa Sa tries on new e-commerce face in China as its Hong Kong core shrinks
0178.HK
-
Biogene gets bruised in ‘Battle of the skincare belles’
2367.HK 688363.SHG
-
Stumbling Transsion hopes global investors overlook its fading fortunes
688036.SHG
- Neautus looks outward to boost its traditional medicine story
- Sinotau aims to become Hong Kong’s ‘first nuclear-medicine stock’
- Intsig scans global financial markets for cash with Hong Kong IPO
